CITIC-controlled Harbin Pharma to acquire 40% of US retailer GNC for $300m

CITIC Capital-controlled Harbin Pharmaceutical Group (Hayao) on Wednesday announced that it has entered into an agreement to acquire a 40 per cent stake in NYSE-listed GNC Holdings and also form a China joint venture with the latter.

Continue reading this story with a subscription to DealStreetAsia.


Should your colleagues be reading this article too? Contact us for corporate subscriptions at